VALHI INC /DE/ VHI

Healthcare SIC 2810 - Industrial Inorganic Chemicals NYSE

Last close 17.83 2026-09-04
Market cap $505.0M 2026-06-30 share count
52-week range 11.44 - 19.19

Valuation FY2025 figures against the last close

P/S0.2x
P/E
P/FCF
EV/EBITDA8.0x
Dividend yield1.8%
Diluted EPS-2.02

Annual financial statements

Income statement

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue $2.08B$2.10B$1.92B$2.22B$2.30B$1.85B$1.90B$1.82B$1.88B$1.52B
Cost of revenue $1.78B$1.68B$1.68B$1.73B$1.72B$1.44B$1.46B$1.21B$1.27B$1.21B
Gross profit $295.4M$424.5M$245.2M$490.4M$580.2M$412.1M$434.6M$609.2M$612.9M$307.9M
R&D $17.0M$14.0M$18.0M$16.0M$17.0M$16.0M$17.0M$16.0M$19.0M$13.0M
SG&A $312.3M$256.2M$277.4M$304.0M$311.9M$283.6M$294.2M$310.0M$262.6M$232.6M
Total operating expenses $2.18B$1.92B$2.00B$2.10B$2.08B$1.78B$1.83B$1.65B$1.61B$1.52B
Operating income $63.3M$210.7M$34.2M$239.4M$318.6M$186.1M$192.7M$370.7M$380.3M$119.2M
Interest expense $57.1M$49.9M$28.3M$27.9M$32.5M$36.2M$40.8M$55.7M$58.9M$58.1M
Pre-tax income -$43.0M$244.2M-$19.5M$169.9M$257.8M$100.6M$104.7M$236.2M$291.8M$39.6M
Income tax $11.9M$82.9M$24.6M$36.8M$60.1M$15.9M$26.5M$30.7M$120.0M$18.6M
Net income -$57.6M$108.0M-$9.9M$87.2M$127.2M$55.2M$49.2M$262.2M$207.5M-$15.9M
EPS, basic -2.023.79-0.353.064.461.941.73
EPS, diluted -2.023.79-0.353.064.461.941.739.200.61-0.05
Shares, diluted (wtd. avg.) $28$28$28$28$28.5M$28.5M$28.5M

Balance sheet

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents $214.0M$348.3M$407.0M$478.5M$698.4M$518.6M$523.8M$499.8M$435.7M$159.7M
Short-term investments $2.9M$1.9M$56.1M$75.1M$2.6M$4.4M$2.1M$2.5M$3.0M
Inventory $659.8M$685.8M$596.1M$640.8M$458.7M$538.2M$522.1M$515.8M$398.4M$359.2M
Total current assets $1.26B$1.45B$1.48B$1.59B$1.67B$1.45B$1.43B$1.41B$1.26B$837.4M
Property, plant and equipment $751.6M$723.4M$517.3M$523.8M$563.6M$590.4M$563.0M$563.5M$588.7M$516.0M
Goodwill $382.3M$382.3M$379.7M$379.7M$379.7M$379.7M$379.7M$379.7M$379.7M$379.7M
Total assets $2.63B$2.80B$2.74B$2.84B$3.01B$2.89B$2.79B$2.71B$2.91B$2.44B
Accounts payable $231.3M$250.0M$228.5M$199.4M$152.7M$117.6M$144.7M$111.5M$116.1M$92.8M
Total current liabilities $449.3M$643.8M$507.1M$492.8M$463.5M$318.1M$322.5M$351.0M$331.1M$294.1M
Retained earnings $508.0M$574.7M$475.8M$482.3M$401.1M$282.9M$239.4M$220.3M-$17.9M-$198.5M
Total equity $1.02B$1.04B$1.28B$1.32B$1.17B$1.01B$980.1M$989.0M$766.7M$444.4M

Cash flow

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Operating cash flow -$35.5M$44.0M$3.9M$34.9M$459.7M$152.2M$177.2M$165.5M$259.3M$79.8M
Capital expenditure $46.6M$30.9M$48.5M$67.6M$64.1M$65.5M$59.9M$61.4M$71.3M$58.9M
Investing cash flow -$47.8M-$125.0M-$29.0M-$146.7M-$37.4M-$57.0M-$50.7M-$57.0M-$74.4M-$61.6M
Financing cash flow -$71.1M-$2.3M-$75.9M-$114.0M-$189.1M-$122.5M-$64.1M-$59.8M$93.6M-$45.5M
Dividends paid $9.1M$9.1M$9.1M$9.0M$9.0M$13.6M$27.1M$27.1M$27.2M$27.1M
Buybacks $2.9M$4.0M$1.5M$1.0M$3.1M

Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001104659-26-025847.

Others in SIC 2810

TickerCompanyMarket capP/ERevenue growth
LIN LINDE PLC $220.15B 32.7x 3.0%
APD Air Products & Chemicals, Inc. $67.09B -0.5%
MTX MINERALS TECHNOLOGIES INC $2.23B -2.2%
KRO KRONOS WORLDWIDE INC $970.3M -1.5%
LXU LSB INDUSTRIES, INC. $813.6M 33.2x 17.8%
TROX Tronox Holdings plc $768.2M -5.7%
LXFR LUXFER HOLDINGS PLC $460.5M 61.5x -1.9%
NL NLI HOLDINGS, INC. $332.0M 8.5%